MonoSol Rx and Midatech Group Ltd announced positive results from a pre-clinical study of insulin PharmFilm(R), an oral insulin film formulation to transbuccally deliver an active therapeutic dose of insulin in a diet-induced diabetic primate model.

The two companies are developing insulin PharmFilm(R) under a partnership that leverages MonoSol Rx's PharmFilm and Midatech's biocompatible nanoparticles to develop orally bioavailable formulations of peptides and drugs. This partnership includes a joint venture set up to focus on the development and commercialization of products combining the two companies' respective technologies in the diabetes field.

Source:

MonoSol Rx